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Viral capsid proteins (CPs) are characterized by their role in forming protective shells around viral
genomes. However, CPs have additional and important roles in the virus infection cycles and in the
cellular responses to infection. These activities involve CP binding to RNAs in both sequence-speciﬁc and
nonspeciﬁc manners as well as association with other proteins. This review focuses on CPs of both plant
and animal-infecting viruses with positive-strand RNA genomes. We summarize the structural features
of CPs and describe their modulatory roles in viral translation, RNA-dependent RNA synthesis, and host
defense responses.
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.Introduction
Positive (+)-strand RNA viruses comprise more than a third of
all virus genera. The genomes of (+)-strand RNA viruses are also
Fig. 1. Potential regulatory activities of viral CPs.
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a dozen proteins. The economy of the genome does not obviate the
need to overcome host defenses as well as to coordinate the
production of viral molecules. Therefore, many viral proteins have
multiple functions, including the structural proteins.
The viral capsid protein (CP) is a structural protein that
accompanies the viral genome into and out of cells. CPs are usually
among the most abundant viral proteins made during infection. In
addition to mediating entry and forming the protective shell for
the viral genome, CPs can regulate viral gene expression, RNA
synthesis and virus-host interactions (Fig. 1).
This review focuses on the non-traditional roles of the CPs of
spherical (+)-strand RNA viruses. Other commonly used names are
coat protein (CP), core protein and nucleocapsid protein. This
review is not intended to be an exhaustive survey of all the
reported regulatory functions of CPs, but to illustrate themes in
animal and plant viruses with (+)-strand RNA genomes and to
provide speciﬁc examples. Our review is an extension of a number
of previous reviews on this subject and we encourage interested
readers to seek them out (Bol, 2008; Callaway et al., 2001;
Urbanowski et al., 2008).Structural features of CP
The function of the CP, including those that are not directly
related to viral genome encapsidation, can best be considered in
the context of the CP structure. CPs of spherical (+)-strand RNA
viruses lack sequence homology and vary in size across genera.
However, several common structural features of the CPs can be
recognized (Rossmann and Johnson, 1989).
The CPs of spherical (+)-strand RNA viruses are generally single
gene products, except for members in families such as Secoviridae
and Picornaviridae. With some exceptions, the CP monomers
contain an extended and highly ﬂexible N-terminal arm (NTA)
followed by a more structured region(s). The structured region
contains a domain that serves to encase the viral RNA, commonly
called the shell (S) domain, and in most cases, a short C-terminal
extension. Alternatively, in taxa such as members of the Tombus-
viridae and Caliciviridae, the S domain is followed by one or more
protruding (P) domain(s) that project outside the capsid
(Rossmann and Johnson, 1989).
Structurally ﬂexible regions in the CP
A signiﬁcant portion of the CPs of both nonenveloped and
enveloped spherical (+)-strand RNA viruses are structurally ﬂex-
ible. In addition to being difﬁcult to resolve in crystallographic
structures, they are likely to be intrinsically disordered (Ivanyi-
Nagy et al., 2008; Liljas, 2011). Intrinsically disordered sequences
are typically characterized by a high proportion of polar and
charged residues and underrepresentation of bulky hydrophobic
residues. Furthermore, intrinsically disordered regions have high
speciﬁcity but lower afﬁnity in their interaction with ligands, a
feature useful for multifunctional proteins (Dunker et al., 2008).
Importantly, proteins with intrinsically disordered regions includeones that act as hubs to mediate a network of protein–protein
interactions (Dunker et al., 2005). This feature likely applies to
viral CPs.
The NTAs of the CPs of spherical (+)-RNA viruses is usually
highly ﬂexible (Fig. 2). They tend to be located within the internal
cavity of the capsid and mediate interaction with RNA. Addition-
ally, members of the Bromoviridae, Tombusviridae, Nodaviridae,
Togaviridae and hepaciviruses of the Flaviviridae have NTAs
enriched with positively-charged residues (Fig. 2: Boulant et al.,
2005; Choi et al., 1991; Fisher and Johnson, 1993; Harrison et al.,
1978; Lucas et al., 2002). Brome mosaic virus (BMV; Bromoviridae)
with mutations in the charged residues of the NTAs exhibited both
a change in the amount and the species of viral RNA encapsidated,
indicating that the charged residues contribute to RNA binding by
a combination of nonspeciﬁc electrostatic interactions and speciﬁc
RNA recognition (Ni et al., 2012).
Additional functions of the NTAs include formation of an
oligomerization network or switching the conformation of CP
during assembly. This has been shown for the CP of the members
of Sobenomvirus, Tombusviridae, Nodaviridae and Caliciviridae
(Abad-Zapatero et al., 1980; Chen et al., 2006; Fisher and
Johnson, 1993; Harrison et al., 1978; Prasad et al., 1999). With
the nonenveloped viruses, the NTA may function in virion trafﬁck-
ing in the cell and/or RNA release. The NTAs of Cowpea chlorotic
mottle virus (CCMV: Bromoviridae) and Cucumber necrosis virus
(CNV; Tombusviridae) are highly sensitive to proteases, suggesting
that they can extend outside of the virion (Kakani et al., 2004;
Speir et al., 2006). Intriguingly, the NTA of the CNV CP facilitates
interaction with cellular ﬁlaments to mediate virion trafﬁcking to
plastids (Xiang et al., 2006). These reports suggest that ﬂexibility
of the CP arms to shuttle from the interior to the exterior of the
capsid are involved in the virion's translocation.
Structured domains of CPs
The structured portion of the CPs displays several distinct folds.
The most prevalent is the “jelly-roll” fold found in almost all the S
domains of the CPs of nonenveloped spherical (+)-strand RNA
viruses (Rossmann and Johnson, 1989). It consists of two back-to-
back four-stranded β-sheets (Fig. 2A) and form the icosahedral
shell with contributions from the extended N- and C-terminal
portion of the CP. Notably, there is high variability in the structure
of the loops that connect the β-strands of the jelly roll fold.
In the cases of Tombusviridae and Caliciviridae, the P domain
that follows the S domain folds into β-barrel conformations
(Fig. 2A; Harrison et al., 1978; Prasad et al., 1999). The P domains
contain binding sites for receptors and undergoes genetic changes
more rapidly in comparison to the S domain (Donaldson et al.,
2010; Katpally et al., 2010). The P domain also participates in the
dimeric interaction of CP subunits and inﬂuences capsid stability
(Bertolotti-ciarlet et al., 2002). Additionally, the hinges between
the P and S domains or between the subdomains within the P
domain are highly ﬂexible, allowing the P domain to rotate for
dimerization or for interaction with receptors (Kakani et al., 2008).
The CP of Leviviridae bacteriophages, such as MS2 has a unique
fold among nonenveloped spherical (+)-strand RNA viruses. The
MS2 CP is entirely ordered and forms a rigid dimer consisting of
two long α-helices juxtaposed on a ﬂat β-sheet (Fig. 2B; Valegård
et al., 1990). In the absence of the terminal arms, the β-sheet is
responsible for interaction with the viral RNA (Valegård et al.,
1994).
The structural domains of enveloped (+)-strand RNA viruses do
not share a common fold. For instance, the C-terminal portion of
the CP of Sindbis virus (SINV; alphaviridae) adopts a chymotrypsin-
like protease topology and is arranged with T¼4 symmetry in the
nucleocapsid core (Fig. 2B, Choi et al., 1991). The central region of
Fig. 2. Schematics and structures of representative CPs of spherical (+)-strand RNA viruses. (A) CPs with jelly roll shell domain and associated motifs. This category includes
majority non-enveloped spherical (+)-strand RNA viruses. Speciﬁc examples used to illustrate the variations in the CPs include the B subunit of an asymmetric trimer of
Brome mosaic virus CP (PDB: 1js9), the B subunit of Flockhouse virus CP (PDB: 4ftb), the VP1, VP2 and VP3 of human rhinovirus 14 (PDB: 4rhv), the C subunit of Turnip
crinkle virus CP (PDB: 3zx8), the B subunit of Norwalk virus VP1 capsid protein (PDB: 1ihm). (B). The CPs of (+)-strand RNA viruses that use alternative structure to form the
capsid. Viruses in this category include the non-enveloped Leviviridae and enveloped spherical (+)-strand RNA viruses. All CPs of enveloped spherical (+)-strand RNA viruses
contain unstructured regions, which may also be enriched for positively charged residues. Examples used are the CP dimer of MS2 bacteriophage (PDB: 2ms2), the CP of
Sindbis virus with chemotrypsin-like shell domain (PDB: 1kxa), the core protein of West Nile virus (PDB: 1sfk), the core protein of Hepatitis C virus (The cylinders represent
putative α-helices), the nucleocapsid protein of SARS-Coronavirus (PDB: 1ssk and 2cjr for the N-and C-terminal structural domain respectively). A key to the structural
elements used in the ﬁgures is in the lower right corner.
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dimerizes through α-helical bundles (Fig. 2B; (Dokland et al.,
2004). The homodimer of WNV core proteins displays basic
residues along one surface for RNA binding, and nonpolar resides
on the other for membrane interaction.
The nucleocapsid (N) protein of the Coronaviridae is the only
exception discussed in this review which wraps the RNA into a
ﬂexible ﬁlamentous ribonucleoprotein complex within the sphe-
rical envelop. The SARS coronavirus (SARS-CoV) N protein contains
N-terminal and C-terminal structural domains that are ﬂanked by
highly ﬂexible termini and a linker region (Fig. 2B). The N-terminal
domain is known as the RNA binding domain and C-terminal
domain as the dimerization domain (Chen et al., 2007; Huang
et al., 2004; Takeda et al., 2008; Yu et al., 2006). However, the C-
terminal dimerization domain and the three ﬂexible regions are
also involved in RNA binding (Chang et al., 2009).
Role of oligomerization
Regulatory activities of viral CPs can be affected by the amount
of CP expressed. The CP concentration that is low in the initial
phase of an infection typically increases dramatically near the end
of one infection cycle. The increase in concentration drives the CPto assemble into higher-ordered structures, and the changes in CP
oligomerization state serves as a regulatory switch to coordinate
the progression of the infection process.
At the molecular level, the high-resolution structures of RNA-
CP complexes involve dimer of CP or of CP peptides (Guogas et al.,
2004; Valegård et al., 1994). Following addition of other dimers,
the dimers of CPs may associate into higher-order intermediates,
such as pentamers of dimers or trimers of dimers, which ulti-
mately leads to the formation of capsid (Prasad et al., 1999;
Rossmann et al., 1985; Sorger et al., 1986). Structures of a number
of spherical (+)-strand RNA viruses have revealed the association
of the RNA density with dimers, pentamers or hexamers of the CPs
(Bottcher and Crowther, 1996; Chen et al., 1989; Fisher and
Johnson, 1993), indicating that the RNA-CP interface may change
with the oligomerization state of the CP. This, in turn, could
inﬂuence the conformation and function of the RNA. The status
of CP oligomerization also dictates its protein–protein interaction
interface, as has been demonstrated for capsid assembly (Stockley
et al., 2007). Although atomic structures of many capsids are well-
characterized, the dynamic interaction between CP subunits or
between CP and RNA is more difﬁcult to capture. Nonetheless, it is
likely that the oligomerization state of CPs signiﬁcantly impact
their regulatory activities.
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activities of the viral CPs: (1) binding to RNA and (2) binding to
other proteins. The propensity for CP to oligomerize in a
concentration-dependent manner further modulates the regula-
tory activities of CPs. We cannot do full justice to the many
systems where CP impacts virus biology. Instead, selective exam-
ples will be used to illustrate these regulatory activities.CP regulation of viral translation
Unlike viruses with double-strand (ds) or negative(-)-strand
RNA genomes, the vast majority of (+)-strand RNA viruses do not
encapsidate replication proteins. Thus, the viral genome must be
translated before replication can ensue. As one of the few, or
possibly the only viral protein present before the initiation of
translation, CPs are likely candidates for having regulatory roles in
the translation of viral proteins. The regulatory roles of CPs involve
interaction with the viral RNA sequences that direct translation as
well as with the cellular translational factors, (Kapp and Lorsch,
2004). Examples selected based on the mechanisms of action are
presented below.
Regulation through CP-RNA binding
The classic example for CP regulating translation comes from
bacteriophage MS2. The MS2 CP dimer binds with low nanomolar
afﬁnity to an RNA hairpin motif that contains the initiation codon
of the viral RNA dependent RNA polymerase (RdRp) and inhibits
translation of the RdRp (Bernardi and Spahr, 1972; Carey et al.,
1983; Lodish and Zinder, 1966). The structure of the CP-RNA
complex exhibits sequence-speciﬁc recognition (Valegård et al.,
1994). Interestingly, the motif regulated by the MS2 CP also
functions as an encapsidation signal during virus assembly
(Beckett and Uhlenbeck, 1988). Several CP mutants defective for
virion assembly suppressed the RdRp translation better than did
the wild type, presumably through elevated concentrations of the
CP dimers (Peabody and Ely, 1992). These ﬁndings illustrate an
interdependence of the structural and regulatory functions of CP,
where CP binding to a speciﬁc RNA motif coordinately regulates
viral RNA replication and virion assembly.
Signiﬁcant insights into CP function in translation have also
been gained from plant-infecting RNA viruses. The CP of the
bacilliform Alfalfa mosaic virus (AMV; Bromoviridae) provides
another well-characterized example of translational regulation.
Successful initiation of AMV infection requires the addition of CP
to the inoculum containing the viral multipartite genome (Bol
et al., 1971). The basic NTR of the CP binds to the conserved 3′
untranslated regions (UTR) present in the AMV RNAs and the
binding is required to activate the genome for infection (Baer et al.,
1994; Zuidema et al., 1983a, 1983b).
The CP of BMV regulates the translation of the multipartite
viral genome in a concentration-dependent manner (Yi et al.,
2009). At a high concentration, the BMV CP binds to an RNA
element named the B box within the 5′ UTRs in two of the BMV
genomic RNAs that encode RNA replication proteins to down-
regulate translation. Interestingly, the CP does not regulate the
genomic RNA that encodes the CP. This mode of regulation could
ensure proper expression of viral replication proteins from the
BMV genomic RNAs.
The Hepatitis C virus (HCV; Flaviviridae) core protein can
speciﬁcally bind the internal ribosome entry site (IRES) in the 5′
UTR of the viral genome to suppress the translation of genes
downstream (Boni et al., 2005; Shimoike et al., 1999). Positively-
charged residues in the N-terminal portion of the HCV core protein
are required for the translation repression (Li et al., 2003;Shimoike et al., 2006). HCV core protein does not act as a simple
translation repressor, however, since it stimulated translation
when expressed at lower concentrations (Boni et al., 2005;
Lourenço et al., 2008).
Regulation through CP-protein interaction
The ability of viral CPs to interact with RNA elements may act in
concert with cellular translation factors. The AMV CP was found to
interact with the host translation initiation factors eIF4G and
eIFiso4G that bind the 5′ cap structure of mRNA (Krab et al.,
2005). Since the AMV CP also binds to the 3′ UTR of the viral RNAs,
interaction with the translation factors that bind to the 5′ UTR will
functionally circularize the capped viral RNAs. This could facilitate
ribosome reloading in translation. Furthermore, the AMV CP is
effectively mimicking the function of host PolyA-binding protein
(PABP) (Neeleman et al., 2001). The CP of Rubella virus (Togavir-
idae) speciﬁcally binds and sequesters the host PABP (Ilkow et al.,
2008). Sequestration of PABP suppresses both the translation of
host mRNAs and the viral RNAs that contain 3′ polyA tails.
Impairing viral RNA translation may promote the encapsidation
of viral RNAs while suppressing translation of host mRNAs perhaps
reduce host immune responses to viral infection (see sections
below).CP regulation of viral RNA synthesis
RNA viruses replicate in specialized environments formed from
cellular membranes, viral replication factories (Den Boon et al.,
2010). Current models suggest that viral replication proteins and
viral RNAs are trafﬁcked to these factories (Ahlquist, 2006).
Although CPs of (+)-strand RNA viruses are not required to form
the factories, viral genome encapsidation is functionally coupled to
its replication for several viruses (Annamalai and Rao, 2006;
Khromykh et al., 2001; Nugent et al., 1999; Venter et al., 2005).
There is also growing evidence that CPs of multiple RNA viruses
have an active role in viral RNA synthesis through binding of the
viral RNA and/or interaction with viral RNA replication-associated
proteins.
Regulating RNA synthesis by CP-RNA interactions
In addition to the effects on translation, binding to the 3′ UTR of
viral RNAs by the AMV CP can regulate RNA synthesis. One model
suggests that the interaction stimulates RNA synthesis by reorga-
nizing the conformation of 3′ UTR to facilitate the recognition of
the promoter for minus-strand synthesis by the viral RdRp
(Guogas et al., 2004; Reichert et al., 2007). An alternative model
proposes that the change in 3′ UTR conformation upon CP binding
blocks RNA synthesis (Chen and Olsthoorn, 2010; Olsthoorn et al.,
1999). A key to reconciling these discrepant observations may be
that the CP strongly stimulated viral RNA replication at low
concentrations, but inhibits replication at higher concentrations
(Guogas et al., 2005). The stepwise binding of CP to multiple
elements in the 3′ UTR of the AMV RNA may switch AMV RNAs
from translation to replication to virion assembly (Petrillo et al.,
2005; Reusken et al., 1994). The BMV CP has also been implicated
in viral RNA replication through its recognition of the promoter for
BMV minus-strand RNA synthesis when present in low amounts
(Yi et al., 2009; Zhu et al., 2007). A single nucleotide change to the
promoter that dramatically reduces BMV RNA replication
(Sivakumaran et al., 1999; Kim and Kao, 2001) also decreases
binding by the CP (Zhu et al., 2007).
The N proteins of the Coronaviridae have been extensively
studied for their participation in viral RNA synthesis. Replicons
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virus (TGEV) both required a functional N gene for efﬁcient
replication (Almazán et al., 2004; Schelle et al., 2005). Further-
more, antiserum speciﬁc to N inhibited Murine hepatitis virus
(MHV) RNA synthesis in vitro (Compton et al., 1987). The N protein
could increase transcription of the nested and 3′ co-terminal
subgenomic mRNAs whose expression is under the control of
transcription-regulating sequences (TRS) (Baric et al., 1988;
Grossoehme et al., 2009; Keane et al., 2012; Zúñiga et al., 2010).
The N-protein remodels the TRS by speciﬁc high-afﬁnity binding
through its N-terminal domain and nonspeciﬁc chaperoning
activity of the disordered and positively charged linker region
(Grossoehme et al., 2009; Keane et al., 2012).
Regulation of RNA synthesis through CP-replication protein
interaction
Both the AMV CP and the SARS-CoV N protein can bind to the
viral replication complex in addition to cis-acting to regulate viral
RNA synthesis (Keane and Giedroc, 2013; Reichert et al., 2007;
Verheije et al., 2010). The HCV core protein binds to a region of
HCV RdRp that encompasses the catalytic site and inhibits RNA
synthesis in vitro (Kang et al., 2009). Exogenous expression of the
core protein in hepatocytes suppressed the replication of the HCV
subgenomic replicon that lacks the core-coding sequence (Kang
et al., 2009). Furthermore, the HCV full-length replicon also
accumulated less efﬁciently than the subgenomic replicon in cells
(Pietschmann et al., 2002).
The CP of Rubella virus binds to the viral replication-associated
protein, P150, and regulates the replication of Rubella virus
replicon (Tzeng et al., 2006). The expression of CP particularly
rescued the replication of a replicon carrying a lethal deletion of
an arginine-rich motif in P150 (Tzeng and Frey, 2003; Tzeng et al.,
2006). Introduction of the CP gene into the deleted region of the
P150 gene yielded a viable subgenomic replicon that accumulated
with wild-type kinetics (Tzeng and Frey, 2009). A cluster of
positively-charged residues close to the RNA-binding region in
the NTA of the CP was necessary for the complementation. This
ﬁnding is unique in that the CP shares a common function with
part of the replication protein, likely RNA binding, for viral RNA
synthesis. Furthermore, the Rubella virus CP enhanced the replica-
tion of subgenomic replicons at low CP levels, but inhibited
replication at high CP levels (Chen and Icenogle, 2004; Tzeng
and Frey, 2005). Whether the effects are due to interaction with
the replication proteins or speciﬁc recognition of the virus RNA
remains to be determined.
Members of the Caliciviridae provide additional examples of CP
regulating RdRp activities. A single amino acid mutation in the P
domain of capsid protein VP1 of Murine norovirus (MNV: Calici-
viridae) attenuated pathogenicity in mice as well as decreased
MNV replication (Bailey et al., 2008; Strong et al., 2012). A MNV
replicon with a frameshift mutation that disrupted VP1 expression
was defective for RNA replication, and expression of VP1 in trans
rescued its replication (Subba-Reddy et al., 2012). Co-expression of
the VP1 and RdRp of the genogroup II.4 human norovirus also
signiﬁcantly enhanced RNA synthesis by the viral RdRp (Ranjith-
Kumar et al., 2011; Subba-Reddy et al., 2012). In this assay, the S
domain of VP1 was necessary and sufﬁcient to increase viral RNA
synthesis.CP regulation of host innate immune responses
Innate immune responses can rapidly active mechanisms to
limit viral infection. The innate immune responses are activated
by receptors that recognize patterns in pathogen molecules.In vertebrates, the activation of these receptors can lead to
interferon (IFN) production. IFN then activates the JAK-STAT path-
way, inducing a suite of antiviral effectors (Versteeg and García-
Sastre, 2010). Viral CPs, along with a suite of other viral proteins,
can interfere with the signaling leading to IFN production and
action (Versteeg and García-Sastre, 2010).
CP regulation of host immune responses is generally mediated
through their interaction with host proteins. In some cases, RNA-
binding by the CP, especially in the plant RNA silencing responses,
can inhibit the host responses.
CP regulation of host responses through CP-protein interactions
Perhaps no other (+)-strand virus has received more attention
than HCV with regard to the innate immune responses. The HCV
core protein interferes with multiple components of the signaling
cascades that lead to IFN production (Arnaud et al., 2010; Bode
et al., 2003; Ciccaglione et al., 2007; de Lucas et al., 2005;
Garaigorta and Chisari, 2009; Heim et al., 1999; Lin et al., 2006;
Oshiumi et al., 2010). The ability of HCV core protein to interact
multiple components of the innate immune pathway is likely
related to core protein possessing regions characterized by intrin-
sic disorder. However, most of the IFN antagonizing mechanisms
proposed for core protein are based on ectopically-expressed
proteins or subgenomic replicons, which recapitulates only some
aspects of the virus infection cycle.
The N protein, among several other viral proteins of the SARS-
CoV, can interfere with IFN production. The N protein inhibits the
activation of transcription factors IRF-3 and NF-κB that control the
transcription of IFN genes (Kopecky-Bromberg et al., 2007; Totura
and Baric, 2012). This activity may require the interaction of N
protein with RNA since the truncated N protein impaired for RNA
binding was debilitated for the ability to antagonize signal
transduction by IFN (Lu et al., 2011).
Alphaviruses suppresses IFN production through the general
down-regulation of host gene expression (Garmashova et al.,
2007). The CPs of the Venezuelan and Eastern equine encephalitis
viruses (VEEV and EEEV) interfere with nucleocytoplasmic traf-
ﬁcking of host mRNAs to decrease cellular gene expression
(Garmashova et al., 2007). This activity is mediated through the
interaction between the ﬂexible N-terminal half of the CP and the
nuclear pore complex (Atasheva et al., 2008, 2010). The EEEV CP
also upregulated phosphorylation of the translation initiation
factor eIF-2a to block the capped mRNA translation (Aguilar
et al., 2007). Similar up-regulation of eIF-2a phosphorylation has
also been suggested for the CP of Semliki forest virus (Favre et al.,
1996).
Plant innate immune receptors are structurally and functionally
similar to their counterparts in animals (Greeff et al., 2012;
Schwessinger and Ronald, 2012). Therefore, it is not surprising
that the plant viral CP can also act in innate immune responses.
The plant Resistance (R) genes, which convey innate immune
response, have been proposed to act either directly through
interactions with the pathogen molecules, or indirectly by guard-
ing cellular proteins that are either required for pathogen infection
or can respond to infection (Knepper and Day, 2010).
R genes products interact with the CPs in several viruses,
including Potato virus X (PVX; Alphaﬂexiviridae), Cucumber mosaic
virus (CMV; Bromoviridae), and Turnip crinkle virus (TCV: Tom-
busviridae) (Kang et al., 2005). The most extensively characterized
is TCV, where a dominant gene HRT (Hypersensitive Response to
TCV) confers hypersensitive response (HR) in the inoculated leaves
to limit TCV spread. A recessive gene, RRT (Regulator of Resistance
to TCV), also contributes to resistance (Cooley et al., 2000; Kachroo
et al., 2000). Overexpression of the CP in seedlings wild-type for
HRT resulted in HR-induced necrosis (Cooley et al., 2000). A
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of developmental regulators in Arabidopsis has been identiﬁed to
bind to the arginine-rich NTA of the TCV CP in the yeast two-
hybrid assay and in vitro (Ren et al., 2000, 2005). The link between
TIP and the R genes is unclear since insertion-inactivation of TIP
did not affect the HR response to TCV infection, although an
increase in CMV infection was observed (Jeong et al., 2008).
CP and apoptosis
Apoptosis plays an important role in the vertebrate immune
system against virus (Barber, 2001). It regulates the development
of immune system cells as well as eliminates the infected cells
(Roulston et al., 1999). There are two pathways to activate
apoptosis (Elmore, 2007). The extrinsic pathway initiates with
recognition of cytokines such as tumor necrosis factor (TNF) by
transmembrane receptors that leads to the activation of effector
caspases. The intrinsic pathway is initiated by a diverse array of
intracellular signals that act on sensors such as p53 and the signals
are propagated to the mitochondria. A loss of mitochondrial
transmembrane potential activates caspases. Not surprisingly,
some viruses can avoid the elicitation of apoptosis. However,
others viruses can stimulate apoptosis as part of their pathogen-
esis or dissemination (Everett and McFadden, 1999). Therefore,
controlling the apoptosis machinery is crucial to the viral infection
cycle. Numerous viral factors, including the viral CP, modulate
apoptosis (Galluzzi et al., 2008).
The HCV core protein affects apoptosis in many different ways
(Jahan et al., 2012). Particularly, it exhibits both pro- and anti-
apoptotic properties, such as its ability to stimulate or suppress
p53 or TNF-mediated apoptosis (Chou et al., 2005; Marusawa
et al., 1999; Otsuka et al., 2000; Ray et al., 1998). The apparently
contradictory functions may be linked to either lytic (activating
apoptosis) or chronic (suppressing apoptosis) HCV infection
(Guicciardi and Gores, 2005). Multiple regions in core protein
have been mapped to interfere with different apoptotic pathways
(Cao et al., 2004; Kang et al., 2009; Mohd-Ismail et al., 2009;
Moorman et al., 2003). However, the relative contributions of
these factors to HCV infection remains to be better characterized
since they will depend on the expression level of core protein, the
cell type, and the apoptotic stimuli.
The core protein of WNV exhibits both suppressive and
stimulatory effects on apoptosis. Expression of WNV core protein
suppresses apoptosis through activation of the phosphatidylinosi-
tol 3 kinase (PI3K) and its downstream target, Akt, a pro-survival
kinase (Urbanowski and Hobman, 2013). In contrast, the precursor
WNV core protein with the C-terminal signal peptide induced p53-
mediated apoptosis (Yang et al., 2008). The precursor core protein
promoted abnormal p53 accumulation by sequestering the HDM2
ubiquitin ligase that targets p53 for degradation. An explanation
for the opposing effects is that the release of core protein following
virus entry inhibits apoptosis in early stages of infection and the
accumulation of the precursor core protein triggers apoptosis later
in the infection cycle (Lee et al., 2005).
The CP of Rubella virus can confer resistance to apoptosis in
infected cells by localizing to the mitochondria and disrupting the
function of Bax, a mitochondrial pro-apoptotic protein (Ilkow
et al., 2011). Importantly, recombinant Rubella virus with mutant
CP that failed to block apoptosis is defective for replication,
implying that the anti-apoptotic activity of CP is essential for
Rubella virus propagation.
Several members of the Picornaviridae have CPs with pro-
apoptotic activity. Expressing recombinant VP1 capsid protein of
the Foot-and-mouth disease virus activated apoptosis through
down-regulation of the Akt pro-survival signaling pathway (Peng
et al., 2004). The VP3 of avian encephalomyelitis virus waslocalized to mitochondria and induced apoptosis (Liu et al.,
2002). Lastly, a single amino acid substitution in the VP1 capsid
protein of Coxsackie virus B2 (CVB2) transformed a noncytolytic
virus to a cytolytic one, causing apoptotic responses that included
caspase activation and DNA fragmentation (Gullberg et al., 2010).
CP affecting host immune responses through RNA binding
Viruses that infect plants, invertebrates and fungi tend to target
the RNA interference (RNAi)-based pathways to overcome the host
immune responses (Ding, 2010). The RNAi pathway uses the
endoribonuclease Dicer to cleave the double-strand viral RNA
replication intermediates. The dsRNA fragments can be unwound
to form the siRNA that can guide the RNA silencing initiator
complex (RISC) to degrade viral RNA through recognition of
complementary sequences. Plant viruses are known to encode a
diverse set of viral suppressors of RNA silencing (Burgyán and
Havelda, 2011). The CP of the TCV is a suppressor of local and
systemic RNA silencing (Qu et al., 2003). The TCV CP may
sequester siRNAs from assembly into RISC complexes through
the N-terminal RNA binding region (Mérai et al., 2006; Thomas
et al., 2003). The TCV CP additionally interacts with the Argonaute
protein 1 (AGO1) to disrupt RISC complex formation and to impact
the availability of Dicer through an AGO1-dependent homeostatic
network (Azevedo et al., 2010; Deleris et al., 2006).Other activities of the CP
Several additional encapsidation-independent activities of viral
CPs deserve mention because of their importance to viral infection
and pathogenesis. Plant viruses move from cell to cell through the
plasmodesmatas and systemically through the plant's vasculature.
These processes are mediated by the viral movement proteins
(MPs), but CPs of some viruses have also been demonstrated to
play a role. Mutation of a single residue on the CP of Carnation
ringspot virus (CRSV: Tombusviridae) abolished virus systemic
infection without disrupting the encapsidation function of the CP
(Sit et al., 2001). A similar effect was observed in the related Red
clover necrotic mosaic virus (Tombusviridae) where virus with
mutations of the CP could systemically infect N. benthamiana only
at a low temperature (Xiong et al., 1993). Deletions in the CP of
Cowpea chlorotic mosaic virus and Cucumber mosaic virus of the
Bromoviridae prevented virion formation yet supported systemic
or local spread of viral RNAs (Kaplan et al., 1998; Schmitz and Rao,
1998; Schneider et al., 1997). Speciﬁc interactions between the MP
and CP and/or between CP and host factors are likely to be
required for these activities.
(+)-strand RNA viruses replicate and assemble in the cyto-
plasm. However, some viruses have a signiﬁcant proportion of
their CP localized to the nucleus (Hiscox, 2003,2007). Nuclear-
localized N protein of SARS-CoV and VP1 capsid protein of
Coxsackie virus B3 (Picornaviridae) have been demonstrated
to induce deregulation of the cell cycle (Surjit et al., 2006;
Wang et al., 2012). For Dengue virus (DENV, Flaviviridae), the core
protein acts as histone mimics to disrupt nucleosome formation
(Colpitts et al., 2011), and the nuclear localization of the DENV core
protein is required to sensitize cells to Fas-induced apoptosis
(Limjindaporn et al., 2007; Netsawang et al., 2010). The nuclear
localization of CP of Japanese encephalitis virus (Flaviviridae) and
the N protein of Porcine reproductive and respiratory syndrome
virus (Coronaviridae) are linked to virus titer and pathogenesis
(Lee et al., 2006; Mori et al., 2005). The diverse functions of the
nuclear localized CP highlight how RNA viruses target the nucleus
to sequester resources for virus replication and to disrupt host
responses.
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The past decade has seen a signiﬁcant expansion in our
understanding of the regulatory functions of CPs in virus infection
cycles and host responses. The CPs of multiple (+)-strand RNA
viruses can regulate viral genome translation and replication and
host cell immune responses. In several cases, the CPs exert both
stimulatory and inhibitory effects on the same viral infection
processes or host responses. This likely reﬂects that the CP
oligomerization is a function of subunit concentration. The state
of oligomerization could change the interaction interface of CPs
and the kinetics of binding to RNAs or proteins. This could, in turn,
inﬂuence interpretation of results from experiments, especially
where the CP was expressed ectopically rather than in the context
of virus infection.
Finally, it is important to note that the regulatory activities of
the CPs of (+)-strand RNA viruses mirror those of nucleocapsid
proteins of (-)-strand and dsRNA viruses (Tao and Ye, 2010).
(-)-strand and dsRNA viruses replicate within virion core
structures or require the presence of the nucleocapsid protein.
The nucleocapsid protein has been shown to bridge the interaction
between RNA template and viral replication proteins (Green and
Luo, 2009), or allosterically regulate replication protein activities
(Lawton et al., 1997; McClain et al., 2010; Newcomb et al., 2009).
Therefore, some of the lessons already learned from viruses whose
infection cycles are more intimately intertwined with the nucleo-
capsid proteins could be instructive to those who study (+)-strand
RNA viruses. Furthermore, most depictions of RNA viruses inaccu-
rately leave the capsid at the surface of the infected cell. This
should be reconsidered, given that some of the CP likely interacts
with the viral and host factors to contribute to the infection
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